[go: up one dir, main page]

HK1162149A - 用於治療骨髓增生異常綜合徵的組合物 - Google Patents

用於治療骨髓增生異常綜合徵的組合物 Download PDF

Info

Publication number
HK1162149A
HK1162149A HK12102720.9A HK12102720A HK1162149A HK 1162149 A HK1162149 A HK 1162149A HK 12102720 A HK12102720 A HK 12102720A HK 1162149 A HK1162149 A HK 1162149A
Authority
HK
Hong Kong
Prior art keywords
ezatiostat
salt
administered
composition
patients
Prior art date
Application number
HK12102720.9A
Other languages
English (en)
Inventor
Gail L. Brown
Original Assignee
Telik, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik, Inc. filed Critical Telik, Inc.
Publication of HK1162149A publication Critical patent/HK1162149A/zh

Links

HK12102720.9A 2010-06-07 2012-03-19 用於治療骨髓增生異常綜合徵的組合物 HK1162149A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US108752 1987-10-15
US352371 2010-06-07

Publications (1)

Publication Number Publication Date
HK1162149A true HK1162149A (zh) 2012-08-24

Family

ID=

Similar Documents

Publication Publication Date Title
EP2969010B1 (en) Use of levocetirizine and montelukast in the treatment of autoimmune disorders
US20110301102A1 (en) Compositions and methods for treating myelodysplastic syndrome
EP2392329B1 (en) Compositions for use in treating myelodysplastic syndrome
EP3884943B1 (en) Application of chidamide in combination with r-chop, and drug combination
HK1162149A (zh) 用於治療骨髓增生異常綜合徵的組合物
WO2013019222A1 (en) Compositions and methods for treating myelodysplastic syndrome
WO2022007982A2 (zh) 一种药物组合物及其应用
MX2011009301A (es) Composiciones y metodos para tratar sindrome mielodisplasico.
HK1162310A (zh) 用於治療骨髓增生異常綜合徵的組合物
US8759303B2 (en) Compositions and methods for treating myelodysplastic syndrome
WO2013019220A1 (en) Compositions and methods for treating myelodysplastic syndrome
TW201306831A (zh) 用於治療骨髓發育不良症候群的組成物及方法
US20240335440A1 (en) Combination therapy comprising a pkc inhibitor and a c-met inhibitor
KR20130020945A (ko) 골수이형성 증후군을 치료하기 위한 조성물 및 방법
KR20130020944A (ko) 골수이형성 증후군을 치료하기 위한 조성물 및 방법
TW201306832A (zh) 用於治療骨髓發育不良症候群的組成物及方法
HK1162147A (zh) 用於治療骨髓增生異常綜合徵的組合物
HK40057612B (zh) 西达本胺联合r-chop的应用及联合药物
Sears et al. 2008 new drug approvals
Edlin Almost half of new molecular entities approved in 2011 considered significant therapeutic advances
KR20130020943A (ko) 골수이형성 증후군을 치료하기 위한 조성물 및 방법
MX2011009305A (es) Composiciones y metodos para tratar sindrome mielodisplasico.
WO2013019221A1 (en) Compositions and methods for treating myelodysplastic syndrome